Literature DB >> 913973

Studies of esophageal epithelial cell proliferation in patients with reflux esophagitis.

E M Livstone, D G Sheahan, J Behar.   

Abstract

Accelerated cell turnover has been held responsible for the basal zone thickening of the esophageal squamous mucosa of patients with reflux esophagitis. We have studied the in vitro proliferative activity of the basal zone in suction biopsy specimens obtained from normal subjects, from patients with medically treated esophagitis, and from patients who had previously undergone anterior fundoplication. In patients with severe esophagitis, the basal zone showed a significantly elevated [3H]thymidine labeling index in contrast to that of mild esophagitis patients and that of normal subjects. When esophagitis was associated with mucosal lesions at endoscopy, the labeling index was higher than that seen in esophagitis patients without endoscopic abnormalities. Significantly increased thymidine labeling was found only in patients with the most severe changes of papillary length or basal layer thickening. We therefore conclude that there is an increased basal zone uptake of [3H]thymidine in severe esophagitis which suggests increased cell turnover as the mechanism for basal zone hyperplasia. Present techniques for measuring mucosal uptake of [3H]thymidine, however, do not permit the distinction of mild degrees of esophagitis from normal epithelium.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 913973

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

1.  Serum and tissue zinc concentrations in patients with endoscopic esophagitis.

Authors:  S C Kadakia; R K Wong; C L Maydonovitch; N R Nelson; R I Henkin
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

Review 2.  Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.

Authors:  Arne Kandulski; Peter Malfertheiner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

Review 3.  The role of acid and bile reflux in oesophagitis and Barrett's metaplasia.

Authors:  Rhonda F Souza
Journal:  Biochem Soc Trans       Date:  2010-04       Impact factor: 5.407

4.  Impact of gastro-esophageal reflux on mucin mRNA expression in the esophageal mucosa.

Authors:  Aafke H C van Roon; George C Mayne; Bas P L Wijnhoven; David I Watson; Mary P Leong; Gabriëlle E Neijman; Michael Z Michael; Andrew R McKay; David Astill; Damian J Hussey
Journal:  J Gastrointest Surg       Date:  2008-05-02       Impact factor: 3.452

5.  Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later.

Authors:  Mark Noar; Patrick Squires; Emmanuelle Noar; Martin Lee
Journal:  Surg Endosc       Date:  2014-02-22       Impact factor: 4.584

6.  Epidermal growth factor receptors in the oesophagus.

Authors:  J Jankowski; S Murphy; G Coghill; A Grant; K G Wormsley; D S Sanders; M Kerr; D Hopwood
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

7.  A critical role of serum response factor in myofibroblast differentiation during experimental oesophageal ulcer healing in rats.

Authors:  Jianyuan Chai; Manith Norng; Andrzej S Tarnawski; Justine Chow
Journal:  Gut       Date:  2006-10-26       Impact factor: 23.059

8.  Evaluation of a murine model of hepatic candidiasis.

Authors:  G T Cole; K T Lynn; K R Seshan
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

9.  In oesophageal squamous cells exposed to acidic bile salt medium, omeprazole inhibits IL-8 expression through effects on nuclear factor-κB and activator protein-1.

Authors:  Xiaofang Huo; Xi Zhang; Chunhua Yu; Qiuyang Zhang; Edaire Cheng; David H Wang; Thai H Pham; Stuart J Spechler; Rhonda F Souza
Journal:  Gut       Date:  2013-09-18       Impact factor: 23.059

10.  Viewpoints on Acid-induced inflammatory mediators in esophageal mucosa.

Authors:  Karen M Harnett; Florian Rieder; Jose Behar; Piero Biancani
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.